Day: August 24, 2020

Simply Green Home Services To Make Friendly, Premium All-Cash Offer to Acquire Dealnet

Written by Customer Service on August 24, 2020. Posted in Public Companies.

Dealnet’s Board unanimously supports the Offer, which will provide shareholders with the opportunity to crystallise the value of their holdings in cashOffer of $0.16 per Common Share represents a premium of 33% to the closing price of the Common Shares on the TSX-V on August 21, 2020, a premium of 52% to the 30-day VWAP on the TSX-V for the period ending August 21, 2020 and a premium of 93%to the 90-day VWAP on the TSX-V for the period ending August 21, 2020Transaction has a total equity value of $47.8 millionTORONTO, Aug. 24, 2020 (GLOBE NEWSWIRE) — Dealnet Capital Corp. (“Dealnet” or the “Company”) (TSX VENTURE: DLS) and Simply Green Home Services Inc. (“Simply Green”), part of the Simply Group of Companies, announced today that they have entered into a definitive support agreement (the “Agreement”), pursuant to which Simply...

Marathon Patent Group Announces Installation of 1,360 Next Generation Miners, Increases Hashrate 130/Ph or 230%

Written by Customer Service on August 24, 2020. Posted in Public Companies.

LAS VEGAS, Aug. 24, 2020 (GLOBE NEWSWIRE) — Marathon Patent Group, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), today announced that it received 700 WhatsMiner M31S+ Miners from MicroBT and 600 S19 Pro Antminers from Bitmain. All 1,360 have been deployed at the Company’s Hosting facility with Compute North, and the new installations have increased the Company’s Hashrate by 130/Ph to 186/Ph.Between May 19, 2020 and June 11, 2020, the Company announced the purchase of 1,000 additional S19 Pro Antminers. 500 of these units are scheduled to arrive in September and another 500 in December of this year. When received and deployed, these 1,000 S-19 Pro Miners will add an additional 110/Ph to the Company’s production (from the 500 installed as a result of the September delivery) and December which will add an additional...

Cassava Sciences Announces Lead Drug Candidate PTI-125 Is Assigned the Chemical Drug Name ‘sumifilam’ by USAN

Written by Customer Service on August 24, 2020. Posted in Public Companies.

– Sumifilam Is First of a New Class of Drugs That Target Filamin Proteins –– A Commercial Brand Name for Sumifilam is Expected at a Future Date –AUSTIN, Texas, Aug. 24, 2020 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that its lead drug candidate PTI-125 has been assigned the chemical drug name sumifilam by the United States Adopted Names (USAN) Council. Future references to PTI-125 will be sumifilam. A commercial brand name for sumifilam is expected to be announced at a future date. Sumifilam is an investigational new drug and has not been approved for any indication.Sumifilam is the first of a new class of drugs that bind filamin proteins. For this reason, USAN is expected to grant this class of drugs its...

Healthier Choices Management Corp Secures $2.5M financing for PPE Initiative

Written by Customer Service on August 24, 2020. Posted in Public Companies.

HOLLYWOOD, FL, Aug. 24, 2020 (GLOBE NEWSWIRE) — Healthier Choices Management Corp. (OTC Pink: HCMC) (“HCMC or the “Company”) announces funding for PPE initiative.The Company announced today that it has secured $2.5M in debt financing to fund its recent PPE initiative.“Keeping in line with providing healthier choices, the Company yesterday secured funding which will allow it to expand its initiative to provide on the ground PPE product, with a focus on customers needing smaller lots and having more price sensitivity”, said Jeff Holman, CEO of Healthier Choices Management Corp.Mr. Holman continued, “We identified a niche market that needs servicing, and we intend to take an ‘old school’ approach of building a consistent book of business for this initiative. The industry has been inundated with “spot sales”, often attempting to sell...

Patient Enrolment Opens in COVID-19 Clinical Trial

Written by Customer Service on August 24, 2020. Posted in Public Companies.

MELBOURNE, Australia, Aug. 24, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the MEND (MEseNchymal coviD-19) Trial is now open for patient enrolment. Following ethics committee approval (as announced on 8 May 2020), this important step represents the formal commencement of this clinical trial. The MEND Trial will investigate early efficacy of Cynata’s proprietary Cymerus™ mesenchymal stem cells (MSCs) in adults admitted to intensive care with COVID-19. Dr. Kilian Kelly, Cynata’s COO, said:“The opening of enrolment of this clinical trial is a major achievement for Cynata. The trial builds on the solid pre-clinical foundations for the use of our Cymerus MSC technology in respiratory diseases, including acute...

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

Written by Customer Service on August 24, 2020. Posted in Mergers And Acquisitions.

Lineagen is a provider of proprietary molecular diagnostics services for individuals showing clinical presentations consistent with neurodevelopmental disorders, including autism spectrum disorder (ASD) and other disorders of childhood developmentAcquisition expands Bionano’s commercial footprint by adding a robust commercial-stage diagnostics services business based on a menu of Laboratory Developed Tests (LDTs) and other services performed in a CLIA-certified environment serving a $1 billion marketLineagen’s team complements Bionano by adding leading cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contractsThe addition of Lineagen gives Bionano a unique and powerful combination of centralized and decentralized solutions for genomics research and clinical genomics...

CloudMD to Acquire Profitable Seven Location Rehabilitation Clinic Network with $5.8 Million in Annual Revenue

Written by Customer Service on August 24, 2020. Posted in Mergers And Acquisitions.

Re:Function Health Group is a leading integrated clinic network offering various rehabilitation services35 Specialists & Allied Professionals including: Occupational Therapists, Physiotherapists, Kinesiologists, Psychologists, Psychiatrists, and CounsellorsCashflow positive business with $5.8 million in annual revenue and EBITDA margins north of 19%This acquisition will provide CloudMD and Re:Function patients with a comprehensive, single stop for their healthcare needsThe acquisition will be immediately accretive given the existing CloudMD patient base will have access to the clinical services offered by Re:FunctionVANCOUVER, British Columbia, Aug. 24, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telehealth company revolutionizing the...

Construction Equipment Market to Rise at 2.8% CAGR till 2027; Growing Popularity of Equipment Rental Services in Construction Sector to Boost the Market: Fortune Business Insights™

Written by Customer Service on August 24, 2020. Posted in Mergers And Acquisitions.

Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) — The global construction equipment market size is projected to reach USD 160.84 billion by 2027, exhibiting a CAGR of 2.8% during the forecast period. Surging demand for construction activities will be one of the primary growth drivers for this market, finds Fortune Business Insights™ in its recent report, titled “Construction Equipment Market Size, Share and COVID-19 Impact Analysis, By Equipment Type (Earthmoving Equipment, Material Handling Equipment & Cranes, Concrete Equipment, Road Building Equipment, Civil Engineering Equipment, Crushing and Screening Equipment and Other Equipment), By Application (Residential, Commercial & Industrial) and Regional Forecast, 2020-2027”.Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/construction-equipment-market-100521An...

OMNIQ Corp. Receives $2.2 Million in Orders from a Worldwide Leader in the Transport and Logistics Sector for Supply of Mobile Data Collection and Communication Devices

Written by Customer Service on August 24, 2020. Posted in Public Companies.

Total project value expected to be approximately $3.0 million in 2020Customer operates over 100 warehouses in the U.S. with over 40 million sq. ft. of warehousing spaceSALT LAKE CITY, Aug. 24, 2020 (GLOBE NEWSWIRE) — OMNIQ Corp. (OTCQB: OMQS) (“OMNIQ” or “the Company”), a provider of Supply Chain and Artificial Intelligence (AI)-based solutions, today announced that it has received orders with a total value of approximately $2.2 million from a leading global transport and logistics company. OMNIQ expects to receive additional orders from the same customer of approximately $0.8 million during the remainder of the third and fourth quarters of 2020. The orders are for the supply of mobile data collection devices equipped with advanced communication capabilities.The customer is an industry-leading third-party logistics (3PL) company...

Genomics Market Size to be Worth US$ 62,614.6 Mn by 2026, Investments by Government to Encourage Growth: Fortune Business Insights

Written by Customer Service on August 24, 2020. Posted in Mergers And Acquisitions.

Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) — In 2018, the Genomics Market Size was valued at US$ 15,888.8 Mn and it is anticipated to reach US$ 62,614.6 Mn by 2026. The gradual shift from traditional medicine to precision medicine is positively changing the healthcare environment. Genomics plays a crucial role in the treatment and diagnosis of chronic diseases. Genomics is most commonly used for the diagnosis of cancer. Recent advancements in personalized medicine and genomics have bought significant transformations in disease management. The growing use of genomics in several clinical trials is reflecting a growing trend. Consequently, the global market is expected to rise at an exponential CAGR of 18.7% between 2018 and 2026.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941Adoption...

Day: August 24, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals